An Open-label, Non-randomized, Single-arm Study, to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma High Density Lipoproteins Concentration in HIV+ Subjects Treated With VIRAMUNE Tablets
Phase of Trial: Phase IV
Latest Information Update: 04 Nov 2013
At a glance
- Drugs Nevirapine (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 10 Jun 2017 Biomarkers information updated
- 27 Jan 2009 Planned patient numbers amended from 15 to 14 as reported by ClinicalTrials.gov.
- 27 Jan 2009 Actual initiation date (Nov 2003) added as reported by ClinicalTrials.gov.